ShareThis Page
Business Headlines

German pharmaceutical firm Bayer cutting 12,000 jobs

| Friday, Nov. 30, 2018, 10:51 a.m.
FILE - In this May 25, 2018 file photo members of the supervisory board sit in front of the company logo during the annual shareholders meeting of German chemical giant Bayer AG in Bonn, Germany. Bayer said Thursday, Nov 29, 2018 it will cut 12 000 jobs, most of them in Germany. (AP Photo/Martin Meissner, file)
FILE - In this May 25, 2018 file photo members of the supervisory board sit in front of the company logo during the annual shareholders meeting of German chemical giant Bayer AG in Bonn, Germany. Bayer said Thursday, Nov 29, 2018 it will cut 12 000 jobs, most of them in Germany. (AP Photo/Martin Meissner, file)

BERLIN — German pharmaceutical giant Bayer AG says it’s cutting 12,000 jobs worldwide as it seeks to reduce costs.

The Leverkusen-based company said Thursday that details of the cuts to its 118,200-stong workforce would be worked out in coming months but that “a significant number” of the reductions would come in Germany.

Bayer acquired U.S. seed and weed-killer maker Monsanto Co. this year. It says with the “synergies expected from the acquisition of Monsanto” and other efficiency and structural measures, including the job cuts, “Bayer anticipates annual contributions of 2.6 billion euros from 2022 on.”

The company says a portion of the funds will be used to strengthen competitiveness and innovation in its divisions.

Bayer shares rose on the news and were up 3 percent in afternoon trading in Frankfurt.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.

click me